KMPHARMACEUTICAL Co.,Ltd. (KOSDAQ:225430)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,585.00
-170.00 (-6.17%)
At close: Apr 13, 2026

KMPHARMACEUTICAL Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Cash & Equivalents
350.62221.05953.37447.752,131
Upgrade
Short-Term Investments
--70.5150235
Upgrade
Trading Asset Securities
-588.92--330.1
Upgrade
Cash & Short-Term Investments
350.62809.971,024597.752,697
Upgrade
Cash Growth
-56.71%-20.89%71.29%-77.83%-54.13%
Upgrade
Accounts Receivable
1,1701,2351,5942,2603,577
Upgrade
Other Receivables
45.4585.26739.4414.15175.58
Upgrade
Receivables
1,2161,3212,3332,2743,753
Upgrade
Inventory
2,0182,4242,3852,4532,759
Upgrade
Prepaid Expenses
154.09140.81202.27256.78591.69
Upgrade
Other Current Assets
31.2321.5537.19763.445.81
Upgrade
Total Current Assets
3,7704,7175,9826,3459,846
Upgrade
Property, Plant & Equipment
20,41521,09621,18322,32525,009
Upgrade
Long-Term Investments
6,7567,4175,5034,6484,202
Upgrade
Other Intangible Assets
20.2114.2429.4167.68105.7
Upgrade
Long-Term Accounts Receivable
60.36----
Upgrade
Long-Term Deferred Tax Assets
--775.71,258720.28
Upgrade
Other Long-Term Assets
7,2277,3058,2208,3077,794
Upgrade
Total Assets
46,39348,97350,55551,28152,676
Upgrade
Accounts Payable
1,249998.73802.07636.391,269
Upgrade
Accrued Expenses
827.95856.861,275603.13898.07
Upgrade
Short-Term Debt
4,8004,0006,0002,5001,000
Upgrade
Current Portion of Long-Term Debt
4,8333,1363,2728,2723,367
Upgrade
Current Portion of Leases
--39.0851.6951.69
Upgrade
Current Income Taxes Payable
----26.12
Upgrade
Current Unearned Revenue
14.6214.620.5812.5732.51
Upgrade
Other Current Liabilities
173.74309.97493.55422.68828.16
Upgrade
Total Current Liabilities
11,8989,31611,88212,4987,473
Upgrade
Long-Term Debt
6,1677,0003,1362,4085,180
Upgrade
Long-Term Leases
---36.5882.62
Upgrade
Other Long-Term Liabilities
61.8441.9459.0810.1534.32
Upgrade
Total Liabilities
18,12716,35815,07714,95312,770
Upgrade
Common Stock
2,7892,7892,7892,7892,789
Upgrade
Additional Paid-In Capital
10,91142,56242,56242,56242,562
Upgrade
Retained Earnings
13,648-14,035-9,462-8,142-4,217
Upgrade
Treasury Stock
-0.17-0.17-0.17-0.17-0.17
Upgrade
Comprehensive Income & Other
918.591,299-410.63-881.32-1,228
Upgrade
Shareholders' Equity
28,26632,61535,47936,32839,906
Upgrade
Total Liabilities & Equity
46,39348,97350,55551,28152,676
Upgrade
Total Debt
15,80014,13612,44713,2689,681
Upgrade
Net Cash (Debt)
-15,449-13,326-11,423-12,671-6,985
Upgrade
Net Cash Per Share
-552.86-477.87-409.62-455.17-251.42
Upgrade
Filing Date Shares Outstanding
28.1227.8927.8927.8927.89
Upgrade
Total Common Shares Outstanding
28.1227.8927.8927.8927.89
Upgrade
Working Capital
-8,128-4,599-5,900-6,1532,373
Upgrade
Book Value Per Share
1005.341169.541272.231302.681430.99
Upgrade
Tangible Book Value
28,24632,60135,44936,26039,800
Upgrade
Tangible Book Value Per Share
1004.621169.031271.171300.261427.20
Upgrade
Land
13,70713,70712,98512,98513,045
Upgrade
Buildings
6,5166,5166,3746,3746,886
Upgrade
Machinery
6,3396,0135,8835,9366,736
Upgrade
Construction In Progress
5.0596.2515.2811.5312.52
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.